MRI in Renal Tumors

Radboud University Medical Center

Status: Completed

Conditions: Renal Cell Carcinoma

Treatments: Device: Magnetic Resonance Imaging

Study type: Observational

Funder types: Other

Identifiers

NCT02325921

NL49616.091.14

Details and patient eligibility

About

Diagnostic imaging for renal masses of unknown nature using conventional imaging modalities such as 3 phase contrast-enhanced computed tomography (CT) is not always conclusive. After (partial) nephrectomy, 10-20 % of the resected tumors show benign histology which could not be identified on diagnostic imaging. With improved imaging techniques available, leading to improvements in characterisation of renal tumors, the number of unnecessary resections may be reduced. The objective of this study is to assess the ability to discriminate oncocytoma from RCC based on the ADC distribution parameters with addition of, tumor volume, and patient demographic characteristics.

Enrollment: 39 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Radiologic diagnosis of renal tumor based on previous ultrasonography, CT or MRI examinations.
• Signed Institutional Review Board (IRB) approved informed consent form.
• Being at least 18 years of age.
• Histopathologically confirmed renal tumor diagnosis.

Exclusion criteria

• Relative contra indications for MRI (metal device/foreign bodies, claustrophobia);
• Active renal or perirenal infection;
• Minor and/or incapacitated adult.

Trial design

39 participants in 1 patient group

Renal tumor.

Description:

Patients \>18 years of age with histopathologically confirmed renal tumor diagnosis.

Treatment:

Device: Magnetic Resonance Imaging